This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Nihon Medi-Physics Company, Limited. Active years: 2003-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Sodegaura, JP (2003)
- Tokyo, JP (2020)
Company Filing History:
Years Active: 2003-2020
Title: The Innovations of Masaru Kanagawa
Introduction
Masaru Kanagawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of diagnostic imaging, particularly in the context of cancer research. With a total of 2 patents, his work has the potential to impact early detection and treatment strategies for cancer patients.
Latest Patents
Kanagawa's latest patents include a diagnostic imaging agent for early bone metastasis from cancer. This innovative agent contains trans-1-amino-[F]fluorocyclobutanecarboxylic acid or a pharmaceutically acceptable salt thereof as an active ingredient. Additionally, he has developed a bisphosphonic acid derivative and a compound thereof labeled with a radioactive nuclide, further enhancing the capabilities of diagnostic imaging in oncology.
Career Highlights
Masaru Kanagawa is currently associated with Nihon Medi-Physics Company, Limited, where he continues to advance his research and development efforts. His work is crucial in the ongoing battle against cancer, providing new tools for early diagnosis and treatment.
Collaborations
Some of his notable coworkers include Osamu Ito and Nobuhiko Kanazashi, who contribute to the collaborative efforts in their research projects.
Conclusion
Masaru Kanagawa's innovative work in diagnostic imaging represents a significant advancement in cancer research. His contributions are paving the way for improved early detection methods, ultimately benefiting patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile